Global Profiling in Vestibular Schwannomas Shows Critical Deregulation of MicroRNAs and Upregulation in Those Included in Chromosomal Region 14q32-Reference-Cited by-同舟云学术

Global Profiling in Vestibular Schwannomas Shows Critical Deregulation of MicroRNAs and Upregulation in Those Included in Chromosomal Region 14q32

Published:2013-06-11 Issue:6 Volume:8 Page:e65868
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Torres-Martin Miguel,Lassaletta Luis,de Campos Jose M.,Isla Alberto,Gavilan Javier,Pinto Giovanny R.,Burbano Rommel R.,Latif Farida,Melendez Barbara,Castresana Javier S.,Rey Juan A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference65 articles.

1. Neurofibromatosis type 2;DG Evans;J Med Genet,2000

2. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas;KD Hadfield;Oncogene,2010

3. Cytogenetic analysis in human neurinomas;JA Rey;Cancer Genet Cytogenet,1987

4. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas;PE Leone;Int J Mol Med,1998

5. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation;C Warren;J Med Genet,2003

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small RNA Deep Sequencing Uncovers microRNAs Associated with Hearing Loss in Vestibular Schwannoma;The Laryngoscope;2024-03-09

2. High-throughput RNA sequencing identifies the miRNA expression profile, target genes, and molecular pathways contributing to growth of sporadic vestibular schwannomas;Acta Neurochirurgica;2024-02-08

3. miR-431 secreted by human vestibular schwannomas increases the mammalian inner ear’s vulnerability to noise trauma;Frontiers in Neurology;2023-10-09

4. Updates on Tumor Biology in Vestibular Schwannoma;Otolaryngologic Clinics of North America;2023-06

5. The genetic landscape and possible therapeutics of neurofibromatosis type 2;Cancer Cell International;2023-05-23